MF

Mohamed Fazal Rabeeh

Active Director Director DIN 11281002
DIN 11281002 First appointment Sep 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamed Fazal Rabeeh

Data last updated:

Mohamed Fazal Rabeeh is a Director at Amoon Pharma Private Limited (since 2025). The company operates in Chemicals.

DIN 11281002
Primary Designation Director
Industry Chemicals
First Appointment 22 Sep 2025
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amoon Pharma Private Limited U24290KL2021PTC069615
Director22 Sep 20252021Active

Board colleagues of Mohamed Fazal Rabeeh

NameDINCompanyDesignation
Amal Mohammed Rabeeh11290489Amoon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amoon Pharma Private Limited
Premium access

Shareholding and investment profile for Mohamed Fazal Rabeeh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamed Fazal Rabeeh

Mohamed Fazal Rabeeh currently holds 1 directorship: Amoon Pharma Private Limited (Director, since 22 Sep 2025).

Mohamed Fazal Rabeeh was first appointed on 22 Sep 2025 as Director at Amoon Pharma Private Limited.

The current boards of Mohamed Fazal Rabeeh's companies include Amal Mohammed Rabeeh (Amoon Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available